Enanta's lung infection therapy succeeds in mid-stage trial
Enanta Pharmaceuticals Inc said on Friday its treatment for a highly contagious respiratory infection met the main goal of reducing virus levels in the body and improving symptoms in patients in a mid-stage study.
from Reuters: Health News https://reut.rs/2MIAVuX
http://bit.ly/2zwRqiM